Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest announcement is out from China Health Group ( (HK:0673) ).
China Health Group Limited has completed a share subscription, issuing 48 million new shares at HK$0.53 each under a general mandate, expanding its share capital by about 3.6 percent. The new shares represent roughly 3.46 percent of the enlarged capital base, slightly diluting existing holdings of major shareholders and public investors while introducing a new subscriber.
The transaction will raise net proceeds of about HK$25.27 million, with around 40 percent earmarked for future investments and the remaining 60 percent allocated to general working capital, including staff costs, rent, and supplier payments. The capital injection is expected to strengthen the group’s liquidity position and support ongoing operations and potential investment opportunities, with controlling shareholders retaining majority control despite marginal dilution.
The most recent analyst rating on (HK:0673) stock is a Hold with a HK$0.58 price target. To see the full list of analyst forecasts on China Health Group stock, see the HK:0673 Stock Forecast page.
More about China Health Group
China Health Group Limited, listed in Hong Kong, operates in the healthcare sector and conducts its business under the name CHG HS Limited. The company focuses on health-related services and investments, using the capital markets to support its operational funding needs and future expansion in its core medical and health businesses.
Average Trading Volume: 402,649
Technical Sentiment Signal: Hold
Current Market Cap: HK$843.7M
See more insights into 0673 stock on TipRanks’ Stock Analysis page.

